fluorouracil has been researched along with Carcinoma, Ehrlich Tumor in 176 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
Carcinoma, Ehrlich Tumor: A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In order to acquire a biochemical fundamental knowledge on the enhancement of antitumor effect with 5-fluorouracil or its masked derivatives, this investigation was undertaken to determine the amounts of antineoplastic metabolic precursors formed from 5-fluorouracil-6-14C in the presence of various substrates by crude enzyme extracts from Ehrlich mouse ascites tumor cells and normal mouse liver." | 7.66 | Additive formation of antineoplastic 5-fluorouracil nucleosides from 5-fluorouracil by Ehrlich ascites tumor extracts in the presence of ribose 1-phosphate/uridine or deoxyribose 1-phosphate/deoxyuridine. ( Tamemasa, O; Tezuka, M, 1982) |
| "In order to acquire a biochemical fundamental knowledge on the enhancement of antitumor effect with 5-fluorouracil or its masked derivatives, this investigation was undertaken to determine the amounts of antineoplastic metabolic precursors formed from 5-fluorouracil-6-14C in the presence of various substrates by crude enzyme extracts from Ehrlich mouse ascites tumor cells and normal mouse liver." | 3.66 | Additive formation of antineoplastic 5-fluorouracil nucleosides from 5-fluorouracil by Ehrlich ascites tumor extracts in the presence of ribose 1-phosphate/uridine or deoxyribose 1-phosphate/deoxyuridine. ( Tamemasa, O; Tezuka, M, 1982) |
| "Antitumor activity of seven 5-fluorouracil derivatives having carbamoyl linkage with amino acid was examined against L-1210 leukemia, adenocarcinoma 755, ascites sarcoma 180, Ehrlich ascites carcinoma and Lewis lung carcinoma by oral administration." | 3.66 | Antitumor activity of 1-alkoxycarbonylalkylcarbamoyl-5-fluorouracil derivatives by oral administration. ( Ando, N; Hoshi, A; Iigo, M; Inomata, M; Kuretani, K, 1981) |
| " In combination therapy with mitomycin C, bleomycin, cyclophosphamide, and 5-fluorouracil, palmitoyldextran phosphate manifested strong synergistic effects against both Sarcoma 180 ascites and L1210 leukemic tumors." | 3.65 | Dextran derivatives in single and combination chemotherapy against transplantable mouse ascites and solid tumors. ( Kadowaki, M; Matsumoto, T; Mikami, T; Suzuki, M; Suzuki, S, 1977) |
| "158 cases of late gastric carcinoma (11 males and 47 females, age 30-70 years) were treated postoperatively with TCM prescriptions of strengthening the patient's resistance and dispelling the invading evil in combination with chemotherapy." | 2.67 | [Treatment of operated late gastric carcinoma with prescription of strengthening the patient's resistance and dispelling the invading evil in combination with chemotherapy: follow-up study of 158 patients and experimental study in animals]. ( Wang, GT, 1990) |
| " The LD50 (lethal dose 50%) value in mice was estimated to be higher than 5000 mg/kg (intraperitoneally)." | 1.51 | Toxicity and Antitumor Activity of a Thiophene-Acridine Hybrid. ( Andrade, C; Duarte, S; Farias, D; Ferreira, R; Lisboa, T; Lopes, AL; Magalhães, H; Medeiros, K; Moura, R; Reis, M; Ribeiro, J; Silva, D; Sobral, M, 2019) |
| " This leads to increased anti-tumour efficacy against SEC, with a reduction in adverse effects." | 1.48 | Polymeric nano-encapsulation of 5-fluorouracil enhances anti-cancer activity and ameliorates side effects in solid Ehrlich Carcinoma-bearing mice. ( El-Gizawy, SA; Faheem, AM; Goda, AE; Haggag, YA; McCarron, PA; Osman, MA; Shamloula, MM, 2018) |
| "Cytotoxicity studies were performed on Ehrlich ascites tumor (EAT) cell lines using MTT cell proliferation assay." | 1.36 | Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil. ( Agarwal, A; Agrawal, GP; Agrawal, H; Jain, S; Mishra, AK; Mishra, P; Rai, G; Yadav, AK, 2010) |
| "Biflorin was active against both tumors with a very similar profile." | 1.34 | Antitumor activity of biflorin, an o-naphthoquinone isolated from Capraria biflora. ( Alves, AP; Bezerra, DP; Costa-Lotufo, LV; Fonseca, AM; Lemos, TL; Moraes, MO; Pereira, MR; Pessoa, C; Pessoa, OD; Vasconcellos, MC, 2007) |
| " Pharmacokinetic studies of 5-FU transdermal patch in rabbits showed half-life 95+/-0." | 1.34 | Transdermal delivery of 5-fluorouracil for induced ehrlich ascites carcinoma tumor in BALB/c mice and pharmacokinetic study. ( Chandrashekar, NS; Hiremath, SR, 2007) |
| " In addition, oral administration of CWSP concurrently with 5-fluorouracil (5-FU) or mitomycin C (MMC), significantly increased tumor regression as compared with the respective chemotherapy alone, illustrating the adjuvant effect of orally administered CWSP for tumor regression when combined with chemotherapeutic agents." | 1.31 | Antitumor and anticytopenic effects of aqueous extracts of propolis in combination with chemotherapeutic agents. ( Fujimiya, Y; Groveman, DS; Hayashi, I; Suzuki, I; Takaki, T, 2002) |
| " The dosage of the oral clinical use for human cancer of 5-FU, HCFU, 5'-DFUR and UFT as tegafur (FT) is 200-300mg/d, 600mg/d, 800-1,200mg/d and 300-600mg/d respectively." | 1.31 | Plasma, intestine and tumor levels of 5-fluorouracil in mice bearing L1210 ascites tumor following oral administration of 5-fluorouracil, UFT (mixed compound of tegafur and uracil), carmofur and 5'-deoxy-5-fluorouridine. ( Higashigawa, M; Kagawa, Y; Kakito, H; Kawasaki, H; Kojima, M; Ohkubo, T; Ooi, A; Sakurai, M, 2001) |
| "In this study, a new dosage form for antitumor agents--nanocapsules was prepared from biodegradable butylcyanoacrylate (BCA)." | 1.28 | [Studies of 5-fluorouracil nanocapsules]. ( Hu, J; Pan, WS, 1991) |
| " On the 9th day after transplantation, HCFU (150 mg/kg) and 5-FU (75 mg/kg) were administered with or without hyperthermia (43." | 1.27 | Enhancement of antitumor effects of 1-hexylcarbamoyl-5-fluorouracil combined with hyperthermia on Ehrlich ascites tumor in vivo and Nakahara-Fukuoka sarcoma cell in vitro. ( Takada, K; Tsumura, M; Yoshiga, K, 1988) |
| "Studies were undertaken with Ehrlich ascites tumor and bone marrow cells isolated from CF-1 mice." | 1.27 | Dihydrofluorouracil, a fluorouracil catabolite with antitumor activity in murine and human cells. ( Diasio, RB; Schuetz, JD; Sommadossi, JP; Wallace, HJ, 1985) |
| " 5'-dFUrd was a more effective antitumor agent and was less toxic over a wide dosage range (50 to 400 mg/kg) than the other agents tested as measured by: (a) the ability to prevent gross development of inoculated tumor; (b) 45-day survival; and (c) weight change over the treatment period." | 1.26 | Metabolism and biological activity of 5'-deoxy-5-fluorouridine, a novel fluoropyrimidine. ( Armstrong, RD; Diasio, RB, 1980) |
| "5-Fluorouracil was administered intraperitoneally for 7 consecutive days from day 9 to 15." | 1.26 | Combined treatment with anaerobic Corynebacterium liquefaciens and chemotherapeutics against solid tumor in mice. ( Hattori, T; Yamagata, S, 1977) |
| "5-Fluorouracil was administered intraperitoneally for 7 consecutive days beginning from the second day after inoculation of tumor cells." | 1.25 | Combination of non-specific immunopotentiation with Corynebacterium liquefaciens and chemotherapy in tumor-bearing mice. ( Hattori, T; Yamagata, S, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 132 (75.00) | 18.7374 |
| 1990's | 17 (9.66) | 18.2507 |
| 2000's | 11 (6.25) | 29.6817 |
| 2010's | 15 (8.52) | 24.3611 |
| 2020's | 1 (0.57) | 2.80 |
| Authors | Studies |
|---|---|
| Sajadi, Z | 3 |
| Almahmood, M | 1 |
| Loeffler, LJ | 5 |
| Hall, IH | 5 |
| Yasumoto, M | 1 |
| Yamawaki, I | 1 |
| Marunaka, T | 1 |
| Hashimoto, S | 1 |
| Andreani, A | 2 |
| Rambaldi, M | 2 |
| Locatelli, A | 2 |
| Bossa, R | 2 |
| Fraccari, A | 2 |
| Galatulas, I | 2 |
| Kundu, NG | 1 |
| Das, B | 1 |
| Spears, CP | 1 |
| Majumdar, A | 1 |
| Kang, SI | 1 |
| Sanyal, U | 1 |
| Mitra, S | 1 |
| Pal, P | 1 |
| Chakraborti, SK | 1 |
| Conway, GA | 1 |
| Holshouser, MH | 1 |
| Kashani, M | 1 |
| Leoni, A | 1 |
| Salvatore, G | 1 |
| Sri Balasubashini, M | 1 |
| Karthigayan, S | 1 |
| Somasundaram, ST | 1 |
| Balasubramanian, T | 1 |
| Viswanathan, V | 1 |
| Raveendran, P | 1 |
| Menon, VP | 1 |
| El-Far, M | 1 |
| Elmegeed, GA | 1 |
| Eskander, EF | 1 |
| Rady, HM | 1 |
| Tantawy, MA | 1 |
| El-Shafei, A | 1 |
| Fadda, AA | 1 |
| Khalil, AM | 1 |
| Ameen, TA | 1 |
| Badria, FA | 1 |
| Vendramini-Costa, DB | 1 |
| de Castro, IB | 1 |
| Ruiz, AL | 1 |
| Marquissolo, C | 1 |
| Pilli, RA | 1 |
| de Carvalho, JE | 1 |
| Reddy, DM | 1 |
| Qazi, NA | 1 |
| Sawant, SD | 1 |
| Bandey, AH | 1 |
| Srinivas, J | 1 |
| Shankar, M | 1 |
| Singh, SK | 1 |
| Verma, M | 1 |
| Chashoo, G | 1 |
| Saxena, A | 1 |
| Mondhe, D | 1 |
| Saxena, AK | 1 |
| Sethi, VK | 1 |
| Taneja, SC | 1 |
| Qazi, GN | 1 |
| Sampath Kumar, HM | 1 |
| El-Sayed, NS | 1 |
| El-Bendary, ER | 2 |
| El-Ashry, SM | 1 |
| El-Kerdawy, MM | 2 |
| Suthar, SK | 1 |
| Jaiswal, V | 1 |
| Lohan, S | 1 |
| Bansal, S | 1 |
| Chaudhary, A | 1 |
| Tiwari, A | 1 |
| Alex, AT | 1 |
| Joesph, A | 1 |
| Vijay Avin, BR | 1 |
| Thirusangu, P | 1 |
| Lakshmi Ranganatha, V | 1 |
| Firdouse, A | 1 |
| Prabhakar, BT | 1 |
| Khanum, SA | 1 |
| Gabr, MT | 1 |
| El-Gohary, NS | 1 |
| Ni, N | 1 |
| Khwaja, S | 1 |
| Fatima, K | 1 |
| Hasanain, M | 1 |
| Behera, C | 1 |
| Kour, A | 1 |
| Singh, A | 1 |
| Luqman, S | 1 |
| Sarkar, J | 1 |
| Chanda, D | 1 |
| Shanker, K | 1 |
| Gupta, AK | 1 |
| Mondhe, DM | 1 |
| Negi, AS | 1 |
| Aboalsoud, A | 1 |
| El-Ghaiesh, SH | 1 |
| Abd Elmonem, FF | 1 |
| Salem, ML | 1 |
| Abdel Rahman, MN | 1 |
| Lisboa, T | 1 |
| Silva, D | 1 |
| Duarte, S | 1 |
| Ferreira, R | 1 |
| Andrade, C | 1 |
| Lopes, AL | 1 |
| Ribeiro, J | 1 |
| Farias, D | 1 |
| Moura, R | 1 |
| Reis, M | 1 |
| Medeiros, K | 1 |
| Magalhães, H | 1 |
| Sobral, M | 1 |
| Gardouh, AR | 1 |
| Barakat, BM | 1 |
| Qushawy, MKE | 1 |
| El-Kazzaz, AY | 1 |
| Sami, MM | 1 |
| Zaitone, SA | 1 |
| Haggag, YA | 1 |
| Osman, MA | 1 |
| El-Gizawy, SA | 1 |
| Goda, AE | 1 |
| Shamloula, MM | 1 |
| Faheem, AM | 1 |
| McCarron, PA | 1 |
| Soliman, NA | 1 |
| Abd-Ellatif, RN | 1 |
| ELSaadany, AA | 1 |
| Shalaby, SM | 1 |
| Bedeer, AE | 1 |
| Jadhav, RL | 1 |
| Magdum, CS | 1 |
| Patil, MV | 1 |
| Gaballah, HH | 1 |
| Gaber, RA | 1 |
| Mohamed, DA | 1 |
| Aminin, DL | 1 |
| Chaykina, EL | 1 |
| Agafonova, IG | 1 |
| Avilov, SA | 1 |
| Kalinin, VI | 1 |
| Stonik, VA | 1 |
| Yadav, AK | 1 |
| Agarwal, A | 1 |
| Rai, G | 1 |
| Mishra, P | 1 |
| Jain, S | 1 |
| Mishra, AK | 1 |
| Agrawal, H | 1 |
| Agrawal, GP | 1 |
| Suzuki, I | 1 |
| Hayashi, I | 1 |
| Takaki, T | 1 |
| Groveman, DS | 1 |
| Fujimiya, Y | 1 |
| Lin, Hs | 1 |
| D'Rosario, T | 1 |
| LINDNER, A | 2 |
| OKADA, TA | 1 |
| ROBERTS, E | 1 |
| SKOLD, O | 1 |
| MAGNUSSON, PH | 1 |
| REVESZ, L | 1 |
| KUTKAM, T | 1 |
| SANKARANARAYANAN, K | 1 |
| RUCKER, R | 1 |
| ARRADONDO, J | 1 |
| BOOTH, BA | 1 |
| SARTORELLI, AC | 1 |
| DIPAOLO, JA | 2 |
| STROUD, AN | 1 |
| MCDONALD, GO | 1 |
| SVOBODA, BR | 1 |
| BRUES, AM | 1 |
| BROCKMAN, RW | 1 |
| ANDERSON, EP | 1 |
| RUTMAN, RJ | 1 |
| PALMA, V | 1 |
| REYERS-DEGLIINNOCENTI, I | 1 |
| GARATTINI, S | 1 |
| HEIDELBERGER, C | 4 |
| BOOHAR, J | 1 |
| BIRNIE, GD | 1 |
| LANGEN, P | 3 |
| PODOLSKY, S | 1 |
| WASE, AW | 1 |
| CARDENAS, J | 1 |
| Mohamed, MM | 1 |
| Mohamed, MA | 1 |
| Fikry, NM | 1 |
| Nyati, MK | 1 |
| Feng, FY | 1 |
| Kanade, VD | 1 |
| Nayak, R | 1 |
| Vasconcellos, MC | 1 |
| Bezerra, DP | 1 |
| Fonseca, AM | 1 |
| Pereira, MR | 1 |
| Lemos, TL | 1 |
| Pessoa, OD | 1 |
| Pessoa, C | 1 |
| Moraes, MO | 1 |
| Alves, AP | 1 |
| Costa-Lotufo, LV | 1 |
| Chandrashekar, NS | 1 |
| Hiremath, SR | 1 |
| Papoian, SA | 1 |
| Kumkumadzhian, VA | 1 |
| Glazer, RI | 1 |
| Hartman, KD | 1 |
| Armstrong, RD | 4 |
| Diasio, RB | 6 |
| Yamamoto, S | 1 |
| Kawasaki, T | 1 |
| Maurer-Schultze, B | 1 |
| Miyoshi, T | 1 |
| Ogawa, S | 1 |
| Nobuhara, M | 1 |
| Namba, M | 1 |
| Bowen, D | 3 |
| Bailey, BD | 1 |
| Guernsey, LA | 1 |
| Tamemasa, O | 7 |
| Tezuka, M | 7 |
| Kurokawa, T | 1 |
| Iwasa, H | 1 |
| Mimura, K | 1 |
| Terashima, H | 1 |
| Hiraide, H | 1 |
| Mizoguchi, O | 1 |
| Kanabe, S | 1 |
| Tamaki, K | 1 |
| Kadota, T | 1 |
| Hatsuse, K | 1 |
| Fujita, H | 2 |
| Ueno, H | 1 |
| Burns, ER | 1 |
| Beland, SS | 1 |
| Connolly, KM | 1 |
| Kaplan, AM | 1 |
| Klein, HO | 1 |
| Wickramanayake, PD | 1 |
| Voigtmann, R | 1 |
| Löffler, T | 1 |
| Mohr, R | 1 |
| Oerkermann, H | 1 |
| Chikaraishi, Y | 1 |
| Mukai, M | 1 |
| Den, N | 1 |
| Yamazaki, Y | 1 |
| Namiki, S | 1 |
| Oda, S | 1 |
| Nagao, K | 1 |
| Shlemkevich, MP | 3 |
| Omukai, Y | 1 |
| Watanabe, S | 1 |
| Nohno, T | 1 |
| Senoo, T | 1 |
| Saito, T | 1 |
| Iurkiv, VA | 1 |
| Melikhov, VI | 1 |
| Miyazaki, S | 3 |
| Ishii, K | 1 |
| Sugibayashi, K | 2 |
| Morimoto, Y | 3 |
| Takada, M | 3 |
| Belousova, AK | 2 |
| Gerasimova, GK | 1 |
| Young, JA | 1 |
| Maruyama, Y | 1 |
| Iigo, M | 3 |
| Hoshi, A | 4 |
| Inomata, M | 1 |
| Ando, N | 1 |
| Kuretani, K | 4 |
| Mazumder, A | 1 |
| Reztsova, VV | 1 |
| Filov, VA | 3 |
| Stukov, AN | 1 |
| Fu, NW | 1 |
| Quan, LP | 1 |
| Akimoto, M | 1 |
| Nadai, T | 1 |
| Kato, Y | 1 |
| Su, J | 1 |
| Zhen, YC | 1 |
| Qi, CQ | 1 |
| Hu, JL | 1 |
| Sur, P | 1 |
| Ganguly, DK | 1 |
| Wang, XW | 1 |
| Xu, B | 1 |
| Ojugo, AS | 1 |
| McSheehy, PM | 2 |
| Stubbs, M | 1 |
| Alder, G | 1 |
| Bashford, CL | 1 |
| Maxwell, RJ | 2 |
| Leach, MO | 1 |
| Judson, IR | 1 |
| Griffiths, JR | 2 |
| Vartanian, LP | 1 |
| Oltarzhevskaia, ND | 1 |
| Vershinina, SF | 1 |
| Gornaeva, GF | 1 |
| Pustovalov, IuI | 1 |
| Korovina, MA | 1 |
| Ooi, A | 1 |
| Ohkubo, T | 1 |
| Higashigawa, M | 1 |
| Kawasaki, H | 1 |
| Kakito, H | 1 |
| Kagawa, Y | 1 |
| Kojima, M | 1 |
| Sakurai, M | 1 |
| Schumann, J | 1 |
| Ehring, F | 1 |
| Gohde, W | 1 |
| Suzuki, M | 1 |
| Mikami, T | 1 |
| Kadowaki, M | 1 |
| Matsumoto, T | 1 |
| Suzuki, S | 1 |
| Sviridenko, OP | 1 |
| Egawa, J | 1 |
| Ishioka, K | 1 |
| Ogata, T | 1 |
| Hecker, D | 1 |
| Rose, H | 1 |
| Powitz, A | 1 |
| Goldman, ID | 2 |
| Shani, J | 1 |
| Wolf, W | 1 |
| Schlesinger, T | 1 |
| Atkins, HL | 1 |
| Bradley-Moore, PR | 1 |
| Casella, V | 1 |
| Fowler, JS | 1 |
| Greenberg, D | 1 |
| Ido, T | 1 |
| Lambrecht, RM | 1 |
| MacGregor, R | 1 |
| Mantescu, C | 1 |
| Neirinckx, R | 1 |
| Som, P | 1 |
| Wolf, AP | 1 |
| Wodinsky, I | 1 |
| Meaney, K | 1 |
| Okada, T | 2 |
| Abrams, DN | 1 |
| Knaus, EE | 1 |
| Wiebe, LI | 1 |
| White, JC | 1 |
| Nakamura, A | 2 |
| Hattori, T | 3 |
| Yamagata, S | 3 |
| Yoshida, M | 1 |
| Takahashi, M | 1 |
| Fujimoto, S | 1 |
| Akao, T | 1 |
| Itoh, B | 1 |
| Koshizuka, I | 1 |
| Koyano, K | 1 |
| Myers, CE | 1 |
| Young, RC | 1 |
| Chabner, BA | 1 |
| Niimoto, M | 1 |
| Tohge, T | 1 |
| Terao, H | 1 |
| Kanamaru, R | 1 |
| Wakui, A | 1 |
| Bose, S | 1 |
| Guha, S | 1 |
| Paul, P | 1 |
| Chowdhury, M | 1 |
| Chowdhury, SR | 1 |
| Sen, U | 1 |
| Miyata, S | 1 |
| Mikami, H | 1 |
| Tai, M | 1 |
| Hori, T | 1 |
| Indap, MA | 3 |
| Ambaye, RY | 3 |
| Pan, WS | 1 |
| Hu, J | 1 |
| Lewin, F | 1 |
| Skog, S | 1 |
| Tribukait, B | 1 |
| Ringborg, U | 1 |
| Wang, GT | 1 |
| Naik, SD | 1 |
| Pertusa, J | 2 |
| Pellicer, JA | 2 |
| Alcober, V | 2 |
| Levin, E | 1 |
| Cherñavsky, A | 1 |
| Takeuchi, S | 1 |
| Sugiyama, M | 2 |
| Hosokawa, M | 1 |
| Koga, Y | 1 |
| Kobayashi, H | 1 |
| Taguchi, T | 1 |
| Severin, E | 1 |
| Hagenhoff, B | 1 |
| Tsumura, M | 1 |
| Yoshiga, K | 1 |
| Takada, K | 1 |
| Rao, XQ | 1 |
| Chiba, Y | 2 |
| Okada, S | 2 |
| Borovskaia, TG | 1 |
| Udintsev, SN | 1 |
| Zueva, EP | 1 |
| Fomina, TI | 1 |
| Neĭshtadt, EL | 1 |
| Osswald, H | 1 |
| Herrmann, R | 1 |
| Jones, GR | 1 |
| Kitta, D | 1 |
| Kunz, W | 1 |
| Yamane, T | 1 |
| Matsuoka, H | 1 |
| Masuda, H | 1 |
| Maehara, Y | 1 |
| Sugimachi, K | 1 |
| Inokuchi, K | 1 |
| Hashiguchi, N | 1 |
| Schuetz, JD | 1 |
| Wallace, HJ | 1 |
| Sommadossi, JP | 1 |
| Knock, FE | 3 |
| Galt, RM | 3 |
| Oester, YT | 3 |
| Sylvester, R | 2 |
| Veselỳ, J | 1 |
| Cihák, A | 1 |
| Erbe, W | 1 |
| Preiss, J | 1 |
| Seifert, R | 1 |
| Hilz, H | 1 |
| Tret'iakov, AV | 2 |
| Riazanov, EM | 2 |
| Weitzel, G | 1 |
| Warnecke, P | 1 |
| Seeber, S | 1 |
| Frankfurt, OS | 1 |
| De Kloet, SR | 1 |
| Andrean, BA | 1 |
| Nakayama, M | 1 |
| Mitsui, R | 1 |
| Chang, YS | 1 |
| Pedicelli, G | 1 |
| Meĭren, DV | 1 |
| Kopper, L | 1 |
| Kiss, J | 1 |
| Lapis, K | 1 |
| Gale, GR | 1 |
| Walker, EM | 1 |
| Atkins, LM | 1 |
| Smith, AB | 1 |
| Meischen, SJ | 1 |
| Marquillo, CL | 1 |
| Esperbén, MT | 1 |
| Pol'kina, RI | 1 |
| Eiselein, J | 1 |
| Biggs, MW | 1 |
| Kuzela, S | 2 |
| Krempaský, V | 2 |
| Bohunická, E | 2 |
| Ujházy, V | 2 |
| Arlen, M | 1 |
| Scherrer, JW | 1 |
| Cukierman, J | 1 |
| Nagin, F | 1 |
| Levowitz, BS | 1 |
| Kent, RJ | 1 |
| Kanzawa, F | 1 |
| Unemi, N | 1 |
| Harima, K | 1 |
| Daidai, Y | 1 |
| Fujihara, H | 1 |
| Fujii, S | 1 |
| Gelderman, AH | 1 |
| Lincoln, TL | 1 |
| Cowie, DB | 1 |
| Roberts, RB | 1 |
| Reeves, WJ | 2 |
| Seid, A | 1 |
| Greenberg, DM | 1 |
| Ishikawa, M | 1 |
| Bollag, W | 1 |
| Ondrus, B | 1 |
| Oravec, C | 1 |
| Cambelová, J | 1 |
| Mériová, M | 1 |
| Hasegawa, Y | 1 |
| Irikura, T | 1 |
| Mizuno, D | 1 |
| Hong, CI | 1 |
| Piantadosi, C | 2 |
| Irvin, JL | 2 |
| Oriuchi, T | 1 |
| Hoshikawa, M | 1 |
| Kondo, T | 1 |
| Ichihashi, H | 1 |
| Sasaki, S | 1 |
| Kanamitsu, Y | 1 |
| Bielka, H | 1 |
| Stahl, J | 1 |
| Chae, CB | 1 |
| Shima, T | 1 |
| Suzuki, K | 1 |
| Kowollik, G | 1 |
| Woods, MW | 1 |
| Burk, D | 1 |
| Gotto, AM | 1 |
| Belkhode, ML | 1 |
| Touster, O | 1 |
| Cailleau, R | 1 |
| Ballweg, H | 1 |
| Schmähl, D | 1 |
| von Wedelstaedt, E | 1 |
| Bennett, LR | 1 |
| Connon, FE | 1 |
4 reviews available for fluorouracil and Carcinoma, Ehrlich Tumor
| Article | Year |
|---|---|
BIOCHEMISTRY OF CANCER (METABOLIC ASPECTS).
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Azaguanine; Azaserine; Carcinoma, Ehrlich Tum | 1963 |
Resistance of mammalian tumour cells toward pyrimidine analogues. A review.
Topics: Animals; Antimetabolites; Azacitidine; Azauridine; Bromouracil; Carcinoma, Ehrlich Tumor; Cell Line; | 1973 |
Fluorinated pyrimidines.
Topics: Animals; Carcinoma, Ehrlich Tumor; Clinical Trials as Topic; DNA; DNA Viruses; Enzyme Induction; Flo | 1965 |
[An inducible enzyme: tryptophan pyrrolase].
Topics: Age Factors; Animals; Carcinoma, Ehrlich Tumor; Enzyme Induction; Enzyme Repression; Female; Fetus; | 1971 |
2 trials available for fluorouracil and Carcinoma, Ehrlich Tumor
| Article | Year |
|---|---|
[Treatment of operated late gastric carcinoma with prescription of strengthening the patient's resistance and dispelling the invading evil in combination with chemotherapy: follow-up study of 158 patients and experimental study in animals].
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ehrlich Tumor; Comb | 1990 |
Fluorinated pyrimidines.
Topics: Animals; Carcinoma, Ehrlich Tumor; Clinical Trials as Topic; DNA; DNA Viruses; Enzyme Induction; Flo | 1965 |
171 other studies available for fluorouracil and Carcinoma, Ehrlich Tumor
| Article | Year |
|---|---|
Antitumor and antiinflammatory agents: N-benzoyl-protected cyanomethyl esters of amino acids.
Topics: Acetonitriles; Amino Acids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; | 1979 |
Studies on antitumor agents, 2. Syntheses and antitumor activities of 1-(tetrahydro-2-furanyl)-5-fluorouracil and 1,3-bis(tetrahydro-2-furanyl)-5-fluorouracil.
Topics: Animals; Antineoplastic Agents; Carcinoma 256, Walker; Carcinoma, Ehrlich Tumor; Fluorouracil; Letha | 1978 |
Antineoplastic agents. 2. Structure-activity studies on N-protected vinyl, 1,2-dibromoethyl, and cyanomethyl esters of several amino acids.
Topics: Acetonitriles; Amino Acids; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Carcinoma, Ehrlic | 1977 |
Potential antitumor agents. 21. Structure determination and antitumor activity of imidazo[2,1-b]thiazole guanylhydrazones.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Female; Hydrazones; Imidazoles; Mice; Mole | 1992 |
Synthesis and biological activities of novel 5-(2-acylethynyl)uracils.
Topics: Animals; Antimetabolites, Antineoplastic; Carcinoma, Ehrlich Tumor; Cell Division; Cell Survival; Dr | 1990 |
New alpha-methylene gamma-lactone derivatives of substituted nucleic acid bases as potential anticancer agents.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Kinetics; Magnetic Resonance Spectroscopy; | 1986 |
Synthesis and antitumor evaluation of selected 5,6-disubstituted 1(2)H-indazole-4,7-diones.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cell Division; Indazoles; Leukemia P388; M | 1983 |
Synthesis and antitumor activity of a series of sulfone analogues of 1,4-naphthoquinone.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Chemical Phenomena; Chemistry; Cyclic S-Ox | 1981 |
Antitumor agents: diazomethyl ketone and chloromethyl ketone analogues prepared from N-tosyl amino acids.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Diazomethane; Ketones; Leukemia P388; Male | 1980 |
Potential antitumor agents. 24. Synthesis and pharmacological behavior of imidazo[2,1-b]thiazole guanylhydrazones bearing at least one chlorine.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cardiotonic Agents; Chlorine; Drug Screeni | 1996 |
Fish venom (Pterios volitans) peptide reduces tumor burden and ameliorates oxidative stress in Ehrlich's ascites carcinoma xenografted mice.
Topics: Animals; Carcinoma, Ehrlich Tumor; Fish Venoms; Fishes; Lethal Dose 50; Mice; Oxidative Stress; Tran | 2006 |
Novel modified steroid derivatives of androstanolone as chemotherapeutic anti-cancer agents.
Topics: Animals; Antineoplastic Agents; Body Weight; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Ce | 2009 |
Synthesis, antitumor evaluation, molecular modeling and quantitative structure-activity relationship (QSAR) of some novel arylazopyrazolodiazine and triazine analogs.
Topics: Animals; Antineoplastic Agents; Azo Compounds; Carcinoma, Ehrlich Tumor; Casein Kinase II; Catalytic | 2009 |
Effect of goniothalamin on the development of Ehrlich solid tumor in mice.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Carrageenan; Cel | 2010 |
Design and synthesis of spiro derivatives of parthenin as novel anti-cancer agents.
Topics: 4-Butyrolactone; Animals; Antineoplastic Agents; Blotting, Western; Carcinoma, Ehrlich Tumor; Cell C | 2011 |
Synthesis and antitumor activity of new sulfonamide derivatives of thiadiazolo[3,2-a]pyrimidines.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; DNA; Drug Screening Assays, Antitumor; Mag | 2011 |
Novel quinolone substituted thiazolidin-4-ones as anti-inflammatory, anticancer agents: design, synthesis and biological screening.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Apoptosis; Carcinoma, Ehrlich Tumor; Carra | 2013 |
Synthesis and tumor inhibitory activity of novel coumarin analogs targeting angiogenesis and apoptosis.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Benzophenones; Carcinoma, Ehrlic | 2014 |
Isatin-β-thiocarbohydrazones: Microwave-assisted synthesis, antitumor activity and structure-activity relationship.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Ehrlich Tumor; Cell Proliferation; Chlorocebus | 2017 |
Antiproliferative efficacy of curcumin mimics through microtubule destabilization.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cell Cycle; Cell Line, Tumor; Cell Prolife | 2018 |
The effect of low-dose naltrexone on solid Ehrlich carcinoma in mice: The role of OGFr, BCL2, and immune response.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Ehrlich Tumor; Cell L | 2020 |
Toxicity and Antitumor Activity of a Thiophene-Acridine Hybrid.
Topics: Acridines; Animals; Antineoplastic Agents; Ascitic Fluid; Biomarkers; Carcinoma, Ehrlich Tumor; Cell | 2019 |
Antitumor activity of a molecularly imprinted nanopreparation of 5-flurouracil against Ehrlich's carcinoma solid tumors grown in mice: Comparison to free 5-flurouracil.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Cell Proliferation; Dose | 2018 |
Polymeric nano-encapsulation of 5-fluorouracil enhances anti-cancer activity and ameliorates side effects in solid Ehrlich Carcinoma-bearing mice.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Drug Compounding; Female; Fluorouracil; Mi | 2018 |
Luteolin and 5-flurouracil act synergistically to induce cellular weapons in experimentally induced Solid Ehrlich Carcinoma: Realistic role of P53; a guardian fights in a cellular battle.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ehrlich Tumor; Caspase 3; Drug S | 2019 |
Synthesis and anticancer evaluation of furfurylidene 4-piperidone analogs.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cell Survival; Doxorubicin; Drug Design; F | 2014 |
Apigenin potentiates the antitumor activity of 5-FU on solid Ehrlich carcinoma: Crosstalk between apoptotic and JNK-mediated autophagic cell death platforms.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apigenin; | 2017 |
Antitumor activity of the immunomodulatory lead Cumaside.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Cholesterol; Female; Flu | 2010 |
Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.
Topics: Animals; Biocompatible Materials; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Chemistry, Pharmaceuti | 2010 |
Antitumor and anticytopenic effects of aqueous extracts of propolis in combination with chemotherapeutic agents.
Topics: Administration, Cutaneous; Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Proto | 2002 |
Pretreatment growth environments alter the sensitivity of tumor cells to cytotoxic agents.
Topics: Agar; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antioxidants; Bleomycin; Carcinom | 2003 |
Cytochemical effects of 5-fluorouracil on sensitive and resistant Ehrlich ascites tumor cells.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Fluorouracil; Neoplasms; Nucleic Acids; Pr | 1959 |
Antimitotic action of 5-(2'-bromo-acetamido)-uracil on the Ehrlich ascites tumor.
Topics: Animals; Antimitotic Agents; Antineoplastic Agents; Carcinoma; Carcinoma, Ehrlich Tumor; Fluorouraci | 1962 |
Studies on resistance against 5-fluorouracil. III. Selective value of resistant, uridine kinase-deficient tumor cells.
Topics: Animals; Carcinoma; Carcinoma, Ehrlich Tumor; Fluorouracil; Humans; Phosphotransferases; Uridine Kin | 1962 |
INHIBITION OF EHRLICH ASCITES TUMOR WITH 5-FLUOROURACIL AND OTHER AGENTS.
Topics: Animals; Antineoplastic Agents; Carcinoma; Carcinoma, Ehrlich Tumor; Floxuridine; Fluorouracil; Hydr | 1963 |
GROWTH INHIBITION OF A SPECTRUM OF TRANSPLANTED MOUSE TUMORS BY COMBINATIONS OF INHIBITORS OF NUCLEIC ACID BIOSYNTHESIS AND ALKYLATING AGENTS.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Azaguanine; Azaserine; Carcinoma, Ehrlich Tumor; | 1963 |
IN VITRO TEST SYSTEMS FOR CANCER CHEMOTHERAPY. II. CORRELATION OF IN VITRO INHIBITION OF DEHYDROGENASE AND GROWTH WITH IN VIVO INHIBITION OF EHRLICH ASCITES TUMOR.
Topics: Animals; Antineoplastic Agents; Arsenicals; Carbamates; Carcinoma; Carcinoma, Ehrlich Tumor; Colchic | 1963 |
UTILIZATION OF DNA AND RNA PRECURSORS AS INDICATORS OF DRUG EFFECT ON CANCER CELLS. ANL-6723.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Dactinomycin; DNA; DNA, Neoplasm; Fluorour | 1963 |
EXPERIMENTAL CHEMOTHERAPY STUDIES. V. THE COLLATERAL SENSITIVITY TO ALKYLATING AGENTS OF SEVERAL ANTIMETABOLITE-RESISTANT ASCITES TUMORS IN MICE.
Topics: Alkylating Agents; Animals; Antimetabolites; Antineoplastic Agents; Ascites; Azaserine; Carcinoma, E | 1964 |
INTERACTION BETWEEN 5-HYDROXYTRYPTAMINE AND ANTITUMOURAL DRUGS.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cyclophosphamide; Fluorouracil; Melphalan; | 1964 |
FLUORINATED PYRIMIDINES. XXII. EFFECTS OF VARIOUS COMPOUNDS ON THE INCORPORATION OF (14C)FORMATE INTO DNA THYMINE IN SUSPENSIONS OF EHRLICH ASCITES CELLS.
Topics: Animals; Antineoplastic Agents; Ascites; Carbon Isotopes; Carcinoma; Carcinoma, Ehrlich Tumor; DNA; | 1964 |
INFLUENCE OF PURINE AND PYRIMIDINE COMPOUNDS ON DNA-SYNTHESIS OF ASCITES-TUMOUR CELLS.
Topics: Animals; Ascites; Carcinoma, Ehrlich Tumor; Cytosine Nucleotides; DNA; DNA, Neoplasm; Fluorouracil; | 1964 |
IN VITRO TEST SYSTEMS FOR CANCER CHEMOTHERAPY. 3. PRELIMINARY STUDIES OF SPONTANEOUS MAMMARY TUMORS IN MICE.
Topics: Alkylating Agents; Animals; Carcinoma, Ehrlich Tumor; Dactinomycin; Fluorouracil; Hydrocortisone; In | 1965 |
Combined action of 5-fluorouracil and other cytotoxic agents with crystalline ribonuclease on mouse ascites tumor.
Topics: Animals; Antineoplastic Agents; Ascites; Carcinoma, Ehrlich Tumor; Cytotoxins; Fluorouracil; Mice; N | 1961 |
Enhancement of antitumor effects of 5-fluorouracil combined with ultrasound on Ehrlich ascites tumor in vivo.
Topics: Animals; Antimetabolites, Antineoplastic; Carcinoma, Ehrlich Tumor; Combined Modality Therapy; Fluor | 2003 |
Chloroquine treatment increases detection of 5-fluorouracil-induced apoptosis index in vivo.
Topics: Animals; Apoptosis; Bone Marrow Cells; Carcinoma, Ehrlich Tumor; Chloroquine; Drug Synergism; Fluoro | 2006 |
Antitumor activity of biflorin, an o-naphthoquinone isolated from Capraria biflora.
Topics: Adjuvants, Immunologic; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; | 2007 |
Transdermal delivery of 5-fluorouracil for induced ehrlich ascites carcinoma tumor in BALB/c mice and pharmacokinetic study.
Topics: Adhesiveness; Administration, Cutaneous; Animals; Antimetabolites, Antineoplastic; Carcinoma, Ehrlic | 2007 |
[Antiblastic effect of various chemotherapeutic preparations on the cells of the Ehrlich ascites tumor].
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Busulfan; Carcinoma, Ehrlich Tumor; Flu | 1966 |
Analysis of the effect of 5-fluorouracil on the synthesis and translation of polysomal poly(A)RNA from Ehrlich ascites cells.
Topics: Adenosine; Animals; Carcinoma, Ehrlich Tumor; Fluorouracil; In Vitro Techniques; Poly A; Protein Bio | 1981 |
Selective activation of 5'-deoxy-5-fluorouridine by tumor cells as a basis for an improved therapeutic index.
Topics: Animals; Biotransformation; Bone Marrow; Carcinoma, Ehrlich Tumor; Cells, Cultured; Floxuridine; Flu | 1981 |
Active transport of 5-fluorouracil and its energy coupling in Ehrlich ascites tumor cells.
Topics: Adenosine Triphosphate; Animals; Biological Transport, Active; Carcinoma, Ehrlich Tumor; Chloromercu | 1981 |
[Autoradiography studies of cell proliferation and the effect of cytostatic agents on the proliferation of normal and tumor cells].
Topics: Animals; Antineoplastic Agents; Autoradiography; Bleomycin; Carcinoma, Ehrlich Tumor; Cell Cycle; Ce | 1983 |
[Potentiation of cytotoxic effects of 5-fluorouracil by inosiplex on cancer cells].
Topics: Animals; Carcinoma, Ehrlich Tumor; Cell Division; Cell Survival; Drug Synergism; Female; Fluorouraci | 1984 |
Rate-limiting steps in the interactions of fluoropyrimidines and methotrexate.
Topics: Animals; Carcinoma, Ehrlich Tumor; Cells, Cultured; Deoxyuridine; DNA, Neoplasm; Drug Interactions; | 1984 |
Metabolism and biological activity of 5'-deoxy-5-fluorouridine, a novel fluoropyrimidine.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cells, Cultured; Chromatography, Liquid; F | 1980 |
Antitumor effect of 5-fluorouracil in combination with some additives which stimulate the formation of antineoplastic 5-fluorouracil nucleotides.
Topics: Animals; Carcinoma, Ehrlich Tumor; Cells, Cultured; Drug Therapy, Combination; Edetic Acid; Fluorour | 1983 |
[Intraperitoneal administration of FT-207 for mouse peritonitis carcinomatosa].
Topics: Animals; Carcinoma, Ehrlich Tumor; Cell Division; Fluorouracil; Injections, Intraperitoneal; Macroph | 1984 |
[Pharmacokinetics of fluoropyrimidines].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ehrlich Tumor; Fluorouracil; Hum | 1984 |
[Effect of adenosine triphosphate on the proliferation of cultured tumor cells].
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cells, Cultured; D | 1984 |
Induction by 5-fluorouracil of a major phase difference in the circadian profiles of DNA synthesis between the Ehrlich ascites carcinoma and five normal organs.
Topics: Animals; Bone Marrow; Carcinoma, Ehrlich Tumor; Circadian Rhythm; DNA; Fluorouracil; Ileum; Male; Mi | 1983 |
Host interactions in the effects of 5-fluorouracil on Ehrlich ascites tumor cells.
Topics: Animals; Carcinoma, Ehrlich Tumor; Cell Cycle; DNA Replication; DNA, Neoplasm; Female; Fluorescent A | 1982 |
High-dose therapy with ftorafur in gastrointestinal cancer.
Topics: Animals; Carcinoma, Ehrlich Tumor; Drug Therapy, Combination; Fluorouracil; Gastrointestinal Neoplas | 1981 |
Increased uptake of 5-fluorouracil by Ehrlich ascites tumor cells with some additives and metabolite analysis.
Topics: Adenosine Triphosphate; Animals; Carcinoma, Ehrlich Tumor; Cell Membrane Permeability; Deoxyuridine; | 1982 |
[Pre-operative chemotherapy of stomach cancer combined with local administration of OK-432--evaluation of macroscopic results].
Topics: Aged; Animals; Antibiotics, Antineoplastic; Biological Products; Carcinoma, Ehrlich Tumor; Drug Ther | 1982 |
[Biochemical differences in the tumor cells of 5-fluorouracil-sensitive and -resistant strains of Ehrlich ascitic carcinoma].
Topics: Animals; Carcinoma, Ehrlich Tumor; Cells, Cultured; Drug Resistance; Fluorouracil; In Vitro Techniqu | 1983 |
Apparent ineffectiveness of adriamycin for growth of androgen-dependent Shionogi carcinoma 115 in the mouse.
Topics: Animals; Carcinoma, Ehrlich Tumor; Cell Division; Cell Line; Doxorubicin; Drug Resistance; Fluoroura | 1983 |
[adenylate cyclase system in Ehrlich ascites tumor cells sensitive and resistant to 5-fluorouracil].
Topics: Adenylyl Cyclases; Animals; Carcinoma, Ehrlich Tumor; Drug Resistance; Fluorouracil; Mice | 1982 |
[Effect of ascorbic acid on incorporation of 5-fluorouracil-6-3H into acid-soluble fraction and into RNA of sensitive and resistant to 5-fluorouracil cells of Ehrlich ascites carcinoma].
Topics: Animals; Ascorbic Acid; Carcinoma, Ehrlich Tumor; Cell Fractionation; Cell Line; Drug Interactions; | 1982 |
Improved measurement of thymidylate synthetase activity by a modified tritium-release assay.
Topics: Animals; Carcinoma, Ehrlich Tumor; Charcoal; Deoxyuracil Nucleotides; Fluorouracil; Methods; Methylt | 1982 |
Additive formation of antineoplastic 5-fluorouracil nucleosides from 5-fluorouracil by Ehrlich ascites tumor extracts in the presence of ribose 1-phosphate/uridine or deoxyribose 1-phosphate/deoxyuridine.
Topics: Animals; Ascites; Carcinoma, Ehrlich Tumor; Deoxyuridine; Fluorouracil; In Vitro Techniques; Liver; | 1982 |
Antitumor effect of ethylene-vinyl acetate copolymer matrices containing 5-fluorouracil on Ehrlich ascites carcinoma in mice.
Topics: Animals; Carcinoma, Ehrlich Tumor; Delayed-Action Preparations; Fluorouracil; Kinetics; Mice; Mice, | 1982 |
Search for the biochemical parameters of tumor cell sensitivity and resistance to antimetabolites.
Topics: Animals; Antimetabolites, Antineoplastic; Carcinoma, Ehrlich Tumor; Cell Line; Drug Resistance; Fluo | 1980 |
5-fluorouracil uptake by irradiation perturbed tumor.
Topics: Animals; Carcinoma, Ehrlich Tumor; DNA, Neoplasm; Fluorouracil; Mice; Mice, Inbred C57BL; Time Facto | 1981 |
Antitumor activity of 1-alkoxycarbonylalkylcarbamoyl-5-fluorouracil derivatives by oral administration.
Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Fema | 1981 |
Increased formation of 5-fluoro-2'-deoxyuridine 5'-monophosphate from 5-fluorouracil in the presence of 2-deoxy-alpha-D-ribose 1-phosphate and 2'-deoxyuridine in Ehrlich ascites tumor cells.
Topics: Animals; Carcinoma, Ehrlich Tumor; Deoxyuracil Nucleotides; Deoxyuridine; Fluorodeoxyuridylate; Fluo | 1980 |
Effect of liposome-entrapped 5-fluorouracil on Ehrlich ascites tumour bearing mice.
Topics: Animals; Carcinoma, Ehrlich Tumor; Cell Survival; Fluorouracil; Kinetics; Liposomes; Male; Mice | 1981 |
[Mechanism of the antitumor action of 5-fluorouracil].
Topics: Animals; Carcinoma, Ehrlich Tumor; DNA, Neoplasm; Fluorouracil; Liver Neoplasms, Experimental; Male; | 1980 |
[Effect of dan-shen and anticancer drugs on the cancer cell surface agglutination induced by phytoagglutinin (author's transl)].
Topics: Agglutination; Animals; Antineoplastic Agents; Asparaginase; Carcinoma, Ehrlich Tumor; China; Fluoro | 1980 |
Drug-carrier property of albumin microspheres in chemotherapy. IV. Antitumor effect of single-shot or multiple-shot administration of microsphere-entrapped 5-fluorouracil on Ehrlich ascites or solid tumor in mice.
Topics: Animals; Carcinoma, Ehrlich Tumor; Fluorouracil; Male; Mice; Microspheres; Neoplasms, Experimental; | 1980 |
Antibiotic C3368-A, a fungus-derived nucleoside transport inhibitor, potentiates the activity of antitumor drugs.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Benzofurans; Biological Transport; Carc | 1995 |
Tea plant root extract (TRE) as an antineoplastic agent.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Ehrlich Tumor; Fluorouracil; Male; Mice; Mice | 1994 |
Stimulation of tumor-cell growth by alpha-fetoprotein.
Topics: alpha-Fetoproteins; Animals; Ascites; Carcinoma, Ehrlich Tumor; Cell Division; Female; Fluorouracil; | 1998 |
Influence of pH on the uptake of 5-fluorouracil into isolated tumour cells.
Topics: Adenocarcinoma; Animals; Biological Transport; Carbon Radioisotopes; Carbonyl Cyanide p-Trifluoromet | 1998 |
[Antineoplastic activity of 5-fluorouracil upon transdermal adminstration using "Coletex" napkins].
Topics: Administration, Cutaneous; Animals; Antimetabolites, Antineoplastic; Carcinoma, Ehrlich Tumor; Femal | 2001 |
Plasma, intestine and tumor levels of 5-fluorouracil in mice bearing L1210 ascites tumor following oral administration of 5-fluorouracil, UFT (mixed compound of tegafur and uracil), carmofur and 5'-deoxy-5-fluorouridine.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Drug Combinations; F | 2001 |
Cell synchronization in solid tumors.
Topics: Animals; Bleomycin; Carcinoma, Ehrlich Tumor; Cell Division; Cricetinae; DNA, Neoplasm; Fluorouracil | 1975 |
Dextran derivatives in single and combination chemotherapy against transplantable mouse ascites and solid tumors.
Topics: Animals; Antibody Formation; Antineoplastic Agents; Bleomycin; Carcinoma, Ehrlich Tumor; Cells, Cult | 1977 |
[Uridine kinase, its structure, properties and biological function].
Topics: Animals; Azacitidine; Brain; Carcinoma, Ehrlich Tumor; Chick Embryo; Drug Resistance; Fluorouracil; | 1978 |
Effect of irradiation and chemotherapeutic agents on the capillaries of Ehrlich ascites carcinoma of mice.
Topics: Animals; Bleomycin; Capillaries; Carcinoma, Ehrlich Tumor; Cobalt Radioisotopes; Female; Fluorouraci | 1979 |
[The correlation of in vivo and in vitro effect of cytostatics in transplantated tumours of the mouse (author's transl)].
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Dihydrolipoamide Dehydrogenase; Fluorourac | 1978 |
Distinguishing between membrane transport and intracellular metabolism of fluorodeoxyuridine in Ehrlich ascites tumor cells by application of kinetic and high performance liquid chromatographic techniques.
Topics: Animals; Biological Transport, Active; Carcinoma, Ehrlich Tumor; Cell Membrane; Chromatography, High | 1979 |
Distribution of 18F-5-fluorouracil in tumor-bearing mice and rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Fluo | 1978 |
Anti-tumor activities of 1-Acetyl-3-o-Toluyl-5-Fu.
Topics: Animals; Carcinoma, Ehrlich Tumor; Cell Division; Female; Fluorouracil; HeLa Cells; Leiomyosarcoma; | 1979 |
Tumor uptake of radiolabeled pyrimidine bases and pyrimidine nucleosides in animal models--I. 6-[3H]-5-fluorouracil.
Topics: Animals; Carcinoma, Ehrlich Tumor; Fluorouracil; Half-Life; Lung Neoplasms; Male; Mice; Models, Biol | 1979 |
A basis for fluoropyrimidine-induced antagonism to methotrexate in Ehrlich ascites tumor cells in vitro.
Topics: Animals; Carcinoma, Ehrlich Tumor; Deoxyuridine; DNA, Neoplasm; Drug Therapy, Combination; Fluoroura | 1978 |
Antitumor activity of 1-alkylcarbamoyl derivatives of 5-fluorouracil in a variety of mouse tumors.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Fluorouracil; Leukemia, Ex | 1978 |
Combined treatment with anaerobic Corynebacterium liquefaciens and chemotherapeutics against solid tumor in mice.
Topics: Animals; Carcinoma, Ehrlich Tumor; Cyclophosphamide; Female; Fluorouracil; Immunotherapy; Injections | 1977 |
Antitumor activity of 1-hexylcarbamoyl-5-fluorouracil in a variety of experimental tumors.
Topics: Adenocarcinoma; Administration, Oral; Animals; Ascites; Carcinoma, Ehrlich Tumor; Female; Fluorourac | 1976 |
Combination of non-specific immunopotentiation with Corynebacterium liquefaciens and chemotherapy in tumor-bearing mice.
Topics: Animals; Antineoplastic Agents; Bacterial Vaccines; Carcinoma, Ehrlich Tumor; Corynebacterium; Cyclo | 1975 |
[Radiotherapy combined with halogenated pyrimidines--fundamental and clinical studies (author's transl)].
Topics: Animals; Carcinoma; Carcinoma, Ehrlich Tumor; Female; Fluorouracil; Halogens; Head and Neck Neoplasm | 1975 |
Effect of N1-(2'-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil on nucleic acid and protein biosyntheses in Ehrlich ascites cells.
Topics: Animals; Carcinoma, Ehrlich Tumor; Cells, Cultured; DNA, Neoplasm; Fluorouracil; Furans; Liver; Male | 1976 |
Kinetic alterations induced by 5-fluorouracil in bone marrow, intestinal mucosa, and tumor.
Topics: Animals; Bone Marrow; Carcinoma, Ehrlich Tumor; Cell Division; Deoxyuridine; DNA; DNA, Neoplasm; Dos | 1976 |
Experimental study on the effect of large-dose intratumoral OK-432 administration in mice.
Topics: Animals; Antibiotics, Antineoplastic; Carcinoma, Ehrlich Tumor; Cytarabine; Drug Therapy, Combinatio | 1976 |
[Pharmacokinetic studies on fluorinated pyrimidine in cancer cell and tissue].
Topics: Animals; Carcinoma, Ehrlich Tumor; Colonic Neoplasms; Esophageal Neoplasms; Female; Fluorouracil; Gl | 1992 |
Detection of differential sensitivity to 5-fluorouracil in Ehrlich ascites tumour cells by 19F NMR spectroscopy.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Carcinoma, Ehrlich Tumor; Cell Extracts; Chr | 1991 |
The role of glutathione in evaluating the efficacy of antimetabolites in transplanted tumors.
Topics: Animals; Carcinoma, Ehrlich Tumor; Cell Count; Female; Floxuridine; Fluorouracil; Glutathione; Liver | 1991 |
Competitive binding radioassay for the determination of 5-fluorodeoxyuridine and 5-fluorodeoxyuridine-5'-monophosphate levels in plasma and tumor tissue.
Topics: Animals; Carcinoma, Ehrlich Tumor; Floxuridine; Fluorodeoxyuridylate; Fluorouracil; Kinetics; Lactic | 1991 |
Efficacy of 5-fluorouracil in combination with methoxyphenyl maleamic acid in murine tumors.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ehrlich Tumor; Drug Therapy, Com | 1991 |
Influence of N-(o-methoxyphenyl)-maleimide on 5-fluorouracil cytotoxicity in Ehrlich (ascites) carcinoma.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ehrlich T | 1991 |
[Studies of 5-fluorouracil nanocapsules].
Topics: Animals; Capsules; Carcinoma, Ehrlich Tumor; Drug Carriers; Enbucrilate; Female; Fluorouracil; Liver | 1991 |
Cell death in relation to cell cycle in a mouse ascites tumor growing in vivo after combined treatment with cisplatin and 5-fluorouracil.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ehrlich Tumor; Cell Cycle; Cell | 1990 |
Modulating effect of alpha-[N,N-[bis(2-hydroxyethyl)]-amino-N- (o-methoxyphenyl)-pyrrolidin-2,5-dione on the chemotherapy of murine tumours.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ehrlich Tumor; Drug Synergism; F | 1990 |
Binucleate cells in the Ehrlich ascites tumor. Autoradiographic labeling.
Topics: Animals; Autoradiography; Carcinoma, Ehrlich Tumor; Cell Nucleus; Female; Fluorouracil; Mice; Mice, | 1989 |
Effect of antineoplastic drugs and estradiol on leucine uptake and proliferation of Ehrlich tumor cells.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cell Division; Doxorubicin; Estradiol; Flu | 1989 |
Effect of implanted ethylene-vinyl alcohol copolymer matrices containing 5-fluorouracil on Ehrlich ascites carcinoma.
Topics: Animals; Carcinoma, Ehrlich Tumor; Drug Implants; Fluorouracil; Male; Mice; Mice, Inbred Strains; Po | 1985 |
[5'-DFUR (doxifluridine)].
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Drug Evaluation; Floxuridine; Fluorouracil | 1987 |
Binucleate cells in the Ehrlich ascites tumor. Action of 5-fluorouracil.
Topics: Animals; Carcinoma, Ehrlich Tumor; Cell Nucleus; Dose-Response Relationship, Drug; Female; Fluoroura | 1987 |
[Synchronization of tumor cells with 5-fluorouracil plus uracil and with vinblastine and irradiation of the synchronized cultures. A contribution to combined radio-chemotherapy].
Topics: Animals; Carcinoma, Ehrlich Tumor; Cell Division; Combined Modality Therapy; Fluorouracil; In Vitro | 1988 |
Enhancement of antitumor effects of 1-hexylcarbamoyl-5-fluorouracil combined with hyperthermia on Ehrlich ascites tumor in vivo and Nakahara-Fukuoka sarcoma cell in vitro.
Topics: Animals; Carcinoma, Ehrlich Tumor; Cell Line; Cell Survival; Combined Modality Therapy; Fluorouracil | 1988 |
[Clinical and experimental studies of shengxue tang combined with chemotherapy in the treatment of late-stage gastric cancer].
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ehrlich Tumor; Drug | 1987 |
Mechanisms of potentiation of antitumor activity of 5-fluorouracil by ribothymidine in a mouse tumor system.
Topics: Animals; Carcinoma, Ehrlich Tumor; Drug Synergism; Fluorouracil; In Vitro Techniques; Liver; Male; M | 1986 |
[Dilution of the toxic action of 5-fluorouracil on the mucosa of the small intestine in mice using the sap of plantain].
Topics: Animals; Carcinoma, Ehrlich Tumor; Drug Evaluation, Preclinical; Drug Interactions; Fluorouracil; In | 1987 |
Urinary polyamine excretion by tumor-bearing and tumor-free mice exposed to cyclophosphamide, 5-fluorouracil and 6-mercaptopurine.
Topics: Animals; Carcinoma, Ehrlich Tumor; Creatinine; Cyclophosphamide; Female; Fluorouracil; Mercaptopurin | 1986 |
[Experimental studies on the uptake of anticancer drugs in cancer cells in hyperthermochemotherapy--effects of in vitro and in vivo heating on the uptake of 5-fluorouracil in Ehrlich cells].
Topics: Animals; Carcinoma, Ehrlich Tumor; Cells, Cultured; Combined Modality Therapy; Fluorouracil; Hot Tem | 1986 |
Intratumoral injection of thymidine: enhancement of the antitumor activity and incorporation of 5-fluorouracil into tumor RNA in a murine tumor system.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ehrlich Tumor; Dose-Response Rel | 1986 |
Fibrinogen microspheres as novel drug delivery systems for antitumor drugs.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Fibrinogen; Fluorouracil; Male; Mice; Micr | 1986 |
Enhancement of antitumor activity of 5-fluorouracil by ribothymidine.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ehrlich Tumor; Drug Synergism; F | 1986 |
Dihydrofluorouracil, a fluorouracil catabolite with antitumor activity in murine and human cells.
Topics: Animals; Antineoplastic Agents; beta-Alanine; Breast Neoplasms; Carcinoma, Ehrlich Tumor; Cell Line; | 1985 |
Inhibition of DNA polymerases and neoplastic cells by selected SH inhibitors.
Topics: Animals; Antineoplastic Agents; Arsenicals; Benzoates; Carbon Isotopes; Carcinoma, Ehrlich Tumor; Ch | 1972 |
Increase in RNase and DPNase activities in ascites tumor cells induced by various cytostatic agents.
Topics: Animals; Carcinoma, Ehrlich Tumor; Cell Division; Cell Nucleolus; Cell Nucleus; Colchicine; Dactinom | 1966 |
[Effect of antineoplastic agents on the activity and molecular heterogeneity of lysosomal hydrolases in Ehrlich ascites tumor].
Topics: Acid Phosphatase; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Chromatography, DEAE-Cel | 1974 |
[In vitro effect of antitumor preparations on the hydrolase activity of lysosomes of tumor cells].
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Fluorouracil; Humans; Hydrolases; In Vitro | 1974 |
[Comparative in vitro studies with 5-fluorouracil and some of its derivatives].
Topics: Acyltransferases; Animals; Carbon Isotopes; Carcinoma, Ehrlich Tumor; Cell-Free System; Depression, | 1969 |
Enhancement of the antitumor activity of 5-fluorouracil by drug combinations.
Topics: Animals; Body Weight; Carcinoma, Ehrlich Tumor; Cell Count; Floxuridine; Fluorouracil; Hydroxyurea; | 1973 |
The nucleotides of fluorinated pyrimidines and their biological activities.
Topics: Animals; Carbon Isotopes; Carcinoma, Ehrlich Tumor; Cells, Cultured; Chromatography, Ion Exchange; F | 1971 |
Buoyant density gradient centrifugation of RNA and DNA in alkali iodide solutions.
Topics: Animals; Carcinoma, Ehrlich Tumor; Centrifugation, Density Gradient; Clostridium perfringens; Cytosi | 1971 |
In vitro estimate of sensitivity of individual human tumors to antitumor agents.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Arsenicals; Benzoates; Breast Neoplasms; Carbon Radi | 1974 |
A new approach to the development of anti-cancer agents-5-FU derivatives.
Topics: Animals; Candida albicans; Carcinoma, Ehrlich Tumor; Cells, Cultured; Fatty Acids; Female; Fluoroura | 1974 |
[Experimental anc clinical studies on the sensitivity test for carcinostatic agent from the cytological point of view].
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cells, Cultur | 1972 |
[Radiosensitizing chemical agents. Radiobiological reasons and prospects for their use].
Topics: Acetates; Animals; Bromodeoxyuridine; Bromouracil; Carcinoma, Ehrlich Tumor; Cell Membrane; Cosmic R | 1972 |
[Mechanism of action of ftorafur, a new antineoplastic agent].
Topics: Animals; Anti-Infective Agents; Antineoplastic Agents; Carbon Radioisotopes; Carcinoma, Ehrlich Tumo | 1972 |
Nucleolar alterations in ascites tumour cells induced by 5-fluorouracil treatment.
Topics: Animals; Autoradiography; Carcinoma, Ehrlich Tumor; Cell Nucleolus; DNA; Fluorouracil; Mice; Microsc | 1973 |
Antileukemic properties of dichloro(1,2-diaminocyclohexane)platinum(II).
Topics: Animals; Carcinoma, Ehrlich Tumor; Cells, Cultured; Cisplatin; Cyclophosphamide; DNA, Neoplasm; Drug | 1974 |
[On selection of antineoplastic agents for local use].
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Female; Fluorouracil; In Vitro Techniques; | 1969 |
Observations with a variant of lymphocytic choriomeningitis virus in mouse tumors.
Topics: Animals; Antigens; Carcinoma, Ehrlich Tumor; Female; Fluorouracil; Immunotherapy; Lymphocytic Chorio | 1970 |
Unequal inhibition of RNA synthesis in mitochondria and whole cells of Ehrlich ascites tumour treated with 5-fluorouracil.
Topics: Animals; Carcinoma, Ehrlich Tumor; Fluorouracil; Mice; Mitochondria; Organelle Biogenesis; RNA, Neop | 1972 |
Resistance of amino acid incorporation by mitochondria isolated from Ehrlich ascites tumour cells to the in vivo treatment with 5-fluorouracil.
Topics: Animals; Carbon Isotopes; Carcinoma, Ehrlich Tumor; Cells, Cultured; Fluorouracil; In Vitro Techniqu | 1972 |
Hydron: an implantable device for the delivery of antitumor chemotherapy.
Topics: Absorption; Acrylic Resins; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Fluorouracil; | 1972 |
Fluorinated pyrimidines. XL. The reduction of 5-fluorouridine 5'-diphosphate by ribonucleotide reductase.
Topics: Alcohol Oxidoreductases; Animals; Carcinoma, Ehrlich Tumor; Cell Line; Cells, Cultured; Chromatograp | 1972 |
Antitumor activity of cyclocytidine in a variety of tumors.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cell Line; Cyclization; Cy | 1972 |
[Experimental studies on antineoplastic action of N 1 -(2'-tetrahydrofuryl)-5-fluorouracil (FT-207)--effect on experimental tumors].
Topics: Animals; Body Weight; Carcinoma, Ehrlich Tumor; Fluorouracil; Furans; Mice; Neoplasms, Experimental; | 1971 |
A further correlation between the response of lysogenic bacteria and tumor cells to chemical agents.
Topics: Animals; Bacterial Proteins; Carcinoma, Ehrlich Tumor; Chelating Agents; Chloramphenicol; DNA, Bacte | 1966 |
A new paper chromatography solvent system resolving pyrimidine-pyrimidine riboside-pyrimidine deoxyriboside mixtures.
Topics: Adenine Nucleotides; Animals; Carcinoma, Ehrlich Tumor; Chromatography, Paper; Culture Techniques; C | 1969 |
[Effects of "cell membrane-acting" substances on uptake of anticancer chemotherapeutics by tumor cells--with special reference to mitomycin C uptake by Ehrlich ascites tumor cells in vitro--].
Topics: Animals; Antifungal Agents; Carcinoma, Ehrlich Tumor; Cell Membrane Permeability; DNA, Neoplasm; Flu | 1969 |
Preferential attack on cancer by selected SH inhibitors.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Ascites; Breast Neoplasms; Carcinoma, Ehrlich Tumor; | 1970 |
The place of 5-fluorouracil in experimental and clinical cancer chemotherapy.
Topics: Animals; Carcinoma, Ehrlich Tumor; Fluorouracil; Humans; Mice; Neoplasms; Sarcoma 180 | 1970 |
[Chemotherapy of murine Ehrlich carcinoma and rat Yoshida sarcoma transplanted on hamsters].
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cricetinae; Cyclophosphamide; Fluorouracil | 1970 |
Adverse effect of antitumor drugs on the prevention of metastasis in mice.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cyclophosphamide; Fluorouracil; Male; Merc | 1970 |
Potential anticancer agents. VI. 5-Substituted pyrimidine-6-carboxaldehydes.
Topics: Aldehydes; Animals; Antineoplastic Agents; Carbon Isotopes; Carcinoma, Ehrlich Tumor; Chemical Pheno | 1970 |
[On uptake of 5-FU, 6-MP and methotrexate by ehrlich ascites tumor cells in vitro].
Topics: Adenine; Animals; Carcinoma, Ehrlich Tumor; Cell Membrane; Fluorouracil; In Vitro Techniques; Male; | 1970 |
[Indication for antineoplastic agents and administration methods].
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cyclophosphamide; Fluorouracil; Mice; Tetr | 1971 |
[On the biochemical causes of the cytostatic effect of glyceraldehyde].
Topics: Adenine Nucleotides; Animals; Antineoplastic Agents; Carbon Isotopes; Carcinoma, Ehrlich Tumor; Cell | 1967 |
Fluorinated pyrimidine aldehydes. Inhibition of nucleic acid and protein biosynthesis in Ehrlich ascites carcinoma cells in vitro.
Topics: Animals; Carbon Isotopes; Carcinoma, Ehrlich Tumor; Chromatography, Ion Exchange; Chromatography, Th | 1968 |
[Combined therapy of lung carcinoma with 5-fluorouracil and 60Co irradiation].
Topics: Adult; Aged; Animals; Carcinoma, Ehrlich Tumor; Carcinoma, Squamous Cell; Cobalt Isotopes; Female; F | 1968 |
[5'-desoxy-5'-fluorothymidine, a new inhibitor of the DNA synthesis].
Topics: Animals; Carcinoma, Ehrlich Tumor; Colorimetry; Depression, Chemical; DNA, Neoplasm; Fluorouracil; M | 1968 |
Antiglycolytic activities of 5-fluorouracil and related pyrimidines in mouse ascites carcinoma cells with special reference to inorganic phosphate and glucose.
Topics: Adenine; Animals; Arsenic; Carcinoma, Ehrlich Tumor; Carcinoma, Krebs 2; Deoxyuridine; Fluorouracil; | 1969 |
Stimulatory effects of inosine and deoxyinosine on the incorporation of uracil-2-14-C, 5-fluorouracil-2-14-C, and 5-bromouracil-2-14-C into nucleic acids by Ehrlich ascites tumor cells in vitro.
Topics: Animals; Carbon Isotopes; Carcinoma, Ehrlich Tumor; DNA, Neoplasm; Enzyme Precursors; Fluorouracil; | 1969 |
Mechanism of growth inhibition by 5-fluorouracil. Reversal studies with pyrimidine metabolites in vitro.
Topics: Animals; Carcinoma, Ehrlich Tumor; Culture Techniques; Depression, Chemical; DNA, Neoplasm; Fluorour | 1969 |
[Studies on the cell division inhibitory effect of some purine and pyrimidine derivatives on Paracentrotus lividus and on sarcoma 180 of mice].
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cell Division; Culture Techniques; Echinod | 1969 |
Comparative effects of DL-glyceraldehyde, 6-mercaptopurine, methotrexate and 5-fluorouracil on the Ehrlich ascites carcinoma in vivo.
Topics: Animals; Carcinoma, Ehrlich Tumor; Drug Synergism; Female; Fluorouracil; Glyceraldehyde; Mercaptopur | 1966 |